COMMUNIQUÉS West-GlobeNewswire

-
NANOBIOTIX annonce les premières données de Phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage
01/10/2025 -
NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer
01/10/2025 -
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
01/10/2025 -
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
01/10/2025 -
TOMI Environmental Solutions Appoints Harold W. Paul to Its Board of Directors
01/10/2025 -
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash
01/10/2025 -
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2025 -
CAP Promotes Daniel Cavanaugh to Senior Vice President of Business Development Amid Record Membership Growth
01/10/2025 -
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
01/10/2025 -
Cirtec Medical Appoints Steven Chevillotte to its Board of Directors
01/10/2025 -
The Facial Pain Association (FPA) Highlights Trigeminal Neuralgia and the Facial Pain Community during Facial Pain Awareness Month
01/10/2025 -
EssilorLuxottica finalise l’acquisition d’Optegra
01/10/2025 -
EssilorLuxottica completes acquisition of Optegra
01/10/2025 -
Elixir Medical Announces Key Commercial Milestone With LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL)
01/10/2025 -
Visory Health Delivers $790 Million in Savings on Critical Cardiovascular Medications
01/10/2025 -
CJ Biomaterials launches new PHA platform for extrusion coatings in repulpable and home compostable food serviceware and food packaging applications
01/10/2025 -
Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network’s Excellence Awards 2025
01/10/2025 -
Palisade Bio Announces Pricing of Upsized $120 Million Underwritten Public Offering of Common Stock
01/10/2025 -
Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
01/10/2025
Pages